Validation and Extension Study of the Predictive Model for Intraoperative Hemodynamic Instability in Pheochromocytoma/Paraganglioma Resection - a Single-center, Prospective, Observational Cohort Study
Sponsor: Peking Union Medical College Hospital
Trial Details
| Condition | Pheochromocytoma, Paraganglioma, Hemodynamic Instability, Intraoperative Complications |
| Status | Not_yet_recruiting |
| Participants | 200 |
| Est. Completion | 1 Feb 2028 |
| Last Updated | 7 Apr 2026 |
Primary Outcome
Predictive Model Discrimination (AUROC)
Eligibility Criteria
Inclusion Criteria
Inclusion Criteria: * Age ≥ 18 years. * Diagnosed with pheochromocytoma/paraganglioma by imaging and laboratory tests and scheduled for elective resection. * Planned intraoperative continuous invasive arterial pressure monitoring. * Willing and able to provide written informed consent. * Able to comply with preoperative CGM monitoring, AI agent assessment, and postoperative follow-up. Exclusion Criteria: * Intraoperative hemodynamic data missing ≥20%. * Postoperative histopathology excludes PPGL diagnosis. * Cardiac paraganglioma or metastatic PPGL. * Severe cardiac disease (e.g., severe valvular disease, severe heart failure) that could independently cause intraoperative HDI. * Pregnancy or breastfeeding. * Mental illness, cognitive impairment, or communication barriers that prevent compliance with study procedures. * Refusal to undergo CGM monitoring or AI agent assessment. * Major illness (e.g., acute myocardial infarction, stroke, severe infection) within 3 months prior to surgery. * Severe hepatic or renal insufficiency (Child-Pugh class C, eGFR \<30 ml/min/1.73 m²).
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service